A stock’s 52-week high and low prices can offer a wealth of information about its current standing and prospective future performance. Harvard Bioscience Inc’s current trading price is -90.13% away from its 52-week high, while its distance from the 52-week low is 29.30%. The stock’s price range for this time frame has been between $0.35 and $4.65. The trading volume of the company’s shares in the Healthcare reached around 0.87 million for the day, which was evidently higher than the average daily volume of 0.34 million over the last three months.
In terms of market performance, Harvard Bioscience Inc had a somewhat inconsistent run in. The highest value for the stock in the past year was $4.65 on 04/10/24, while the lowest value was $0.35 on 04/08/25.
How Financial Performance Impacts Market Capitalization
Harvard Bioscience Inc (HBIO) has experienced a quarterly decline of -78.65% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 20.24M and boasts a workforce of 355 employees.
The Role of Moving Averages and Trading Volume in Technical Analysis
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.5173, with a change in price of -1.8210. Similarly, Harvard Bioscience Inc recorded 284,075 in trading volume during the last 100 days, posting a change of -79.87%.
How HBIO’s Debt-to-Equity Ratio Affects Financial Health
A company’s financial condition and market reputation can be evaluated using the debt-to-equity (D/E) ratio. This ratio, calculated by dividing a company’s total liabilities by its shareholders’ equity, indicates the proportion of debt a company employs to back its assets in relation to its shareholders’ equity. At the time of writing, the total D/E ratio for HBIO stands at 0.70. Similarly, the long-term debt-to-equity ratio is also 0.10.
HBIO Stock Stochastic Average
The raw stochastic average for Harvard Bioscience Inc over the last 50 days is presently at 7.36%. This reflects a drop from the raw stochastic average of the previous 20 days, which was noted at 28.68%. Further, the company’s Stochastic %K and %D values for the last 20 days were 12.02% and 6.27%, respectively.
HBIO Stock Price Performance Analysis
A mixed performance in the stock price over the year has left investors with either an optimistic or pessimistic outlook, depending on their point of view. This year’s metric has recorded a Price decrease of -78.25%. However, over the past six months, we’ve seen a stronger performance of -80.88%. The price of HBIO leaped by -39.76% over the last 30 days. And in the last five days, it has fallen by -21.97%.
